Abstract
Background: Antimicrobial drug resistance is of great concern today. Infections by the antimicrobial resistant strains of Escherichia coli, including enteropathogenic as well as enterotoxigenic strains have been reported as a major cause of deaths, especially among young children in low- and middle-income countries. This has been augmented by antimicrobial misuse, over the counter availability and poor sanitation especially in low income areas. This study aimed at characterizing antimicrobial resistant strains of Escherichia coli isolated from sanitation environments of the Majengo slum in Meru County, Kenya Methods: A cross-sectional study was conducted on 61 samples from soil, water and drains swabs. These were tested against five antimicrobial drugs by the Kirby disk diffusion method. Results: A total of 42 (69%) of the samples had Escherichia coli. These recorded antimicrobial drug susceptibility as follows: Out of the five antimicrobial agents used, ceftazidime 28 (66.67%) showed the highest sensitivity followed by ciprofloxacin 26 (61.90%) and imepenem 25 (59.52%) respectively. cefotaxime and cefoxitin showed least sensitivity at 14 (33.33%) and 13 (30.95%) respectively. In intermediate imepenem and ciprofloxacin were the highest with 12 (28.57%) followed by cefotaxime 10 (23.81%). The least intermediate was observed in ceftazidime and cefoxitin both at 7 (16.67%). The highest resistance was observed in cefoxitin 22 (52.38%), followed by cefotaxime at 18 (42.86%). Ciprofloxacin, imepenem and ceftazidime had the lowest resistance 4 (9.52%), 5 (11.91%) and 7 (16.67%) respectively. The p-value <0.05 was considered significant to the study. Conclusions: This study showed that Escherichia coli isolated from Majengo is pathogenic and resistant to antibiotics. Detection of Escherichia coli poses a great risk in the spread of resistant strains in human. Proper sanitation and hygiene awareness practices should be provided through education to the residents of this area.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
